| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |